First to Suffer, First to Heal: The Pancreas, Inflammation, and the Recovery Cascade in Lactation

For decades, the prevailing belief has been that Type II diabetes arises mainly from overeating calories and carbohydrates, with the pancreas eventually “wearing out” under the pressure of producing insulin. But newer research points in a different direction: pancreatic dysfunction, particularly in the beta-cells responsible for insulin secretion, is not primarily a matter of overwork. It is often the result of an inflammatory diet that triggers oxidative stress and disrupts normal cellular function across multiple organ systems.

What starts in the pancreas soon affects the liver, the muscles, and the mammary glands. As metabolic regulation breaks down, fat and inflammatory deposits begin to accumulate in these organs — first subtly, then visibly, as fatty liver, pancreatic lipomatosis, and muscle insulin resistance. This progression reflects not isolated organ failure, but a systemic collapse of metabolic balance.

This inflammation-first perspective is a powerful reframing. It tells us that Type II diabetes shares a common root with many modern diseases — autoimmune conditions, neurodegenerative disorders, cardiovascular disease, and even fertility issues. The culprit is not simply sugar or calories, but a deeper metabolic disturbance triggered by specific inflammatory inputs.

A Note for Mothers

Although we refer to Type II diabetes in this article, the real focus is the wide and often unspoken range of metabolic states that fall short of a diagnosis — from reactive hypoglycemia to prediabetes and beyond. These conditions reflect a spectrum of blood sugar instability and insulin resistance that affects many women, particularly those with PCOS or PCOS-like tendencies.

Importantly, the groundwork for these patterns is often laid in the womb. Women whose mothers experienced insulin resistance, gestational diabetes, or related conditions during pregnancy may carry a predisposition from birth. If that’s your story — or even if you’re not sure — the ideas in this article likely apply to you. For clarity, we won’t restate this background in each section, but you can read the whole article with this context in mind.

Why the Beta-Cells Go First

The beta-cells of the pancreas are among the most sensitive cells in the body. They have a high metabolic demand and a low capacity to neutralize oxidative stress. This makes them particularly vulnerable to inflammatory ingredients — not because those ingredients “target” the pancreas specifically, but because beta-cells are among the first to respond and the first to falter.

The main damaging component is a class of molecules called advanced glycation end-products (AGEs) — large inflammatory compounds formed when sugars react with proteins or fats. Many of the foods listed below contribute to the formation of AGEs, either directly or through metabolic byproducts.

These include:

• • • Excess fructose (especially in processed foods, beverages and juices)
    • Industrial seed oils rich in omega-6 fatty acids
    • Emulsifiers, artificial sweeteners, and food additives
    • Trans fats and advanced glycation end-products (AGEs) in processed foods
    • Environmental toxins like BPA and glyphosate

Together, these compounds create a hostile internal environment that leads to cellular stress, dysfunction, and eventually quiescence — a sort of protective shutdown of beta-cell function. But crucially, many beta-cells do not die. They simply go dormant. Remove the inflammatory inputs, and they may begin to recover.

The Recovery Cascade: Pancreas, Liver, Mammary Gland

Because beta-cells are so sensitive, they may also be among the first to recover when the inflammatory burden is lifted. This sets off a cascade of recovery in the body.

• • • First, the pancreas. With reduced inflammation, beta-cells may emerge from dormancy and resume insulin secretion, stabilizing blood sugar levels and improving metabolic signaling.
  • • Then the liver. The liver is slower to respond but plays a key role in glucose regulation, hormone metabolism, and detoxification. As insulin signaling improves, the liver begins clearing stored fat, restoring bile production, and metabolizing excess estrogens — all critical for reproductive and lactational health.
  • • Finally, the mammary gland. Milk production depends on a finely tuned interplay of insulin, prolactin, and other hormones. Improved insulin sensitivity and reduced inflammation enables the mammary gland to respond more effectively to prolactin, enhancing milk synthesis. A healthier liver further supports this process by maintaining hormonal balance and fat metabolism.

Beyond Linear Thinking

An IBCLC student recently asked, “Which foods or which ingredients in particular target the pancreas?” Her question reveals how we often look for simple cause-and-effect relationships in nutrition. But food doesn’t work that way, and the body is not a linear system. It’s a networked biology, where inputs ripple across tissues, systems, and functions.

So the answer isn’t to simply avoid specific foods. The real work lies in shifting the overall inflammatory profile of the diet — restoring balance in the microbiome, the immune system, and the metabolic pathways that underlie everything from energy production to hormone regulation. 

Implications for Lactation

For mothers, especially those struggling with low milk supply, this shift in thinking is crucial. Supporting lactation isn’t only about hormones and hydration — it’s about metabolic restoration. That means:

• • • Reducing exposure to inflammatory ingredients
    • Supporting liver function with nutrient-dense, detoxifying foods
    • Encouraging blood sugar stability with fiber, fat, and resistant starches
    • Including viscous polysaccharides that modulate the gut and immune system

When we support the pancreas first, we begin a systemic recovery that eventually supports the entire lactation process.

Conclusion

The story of Type II diabetes is not a story of weakness or overeating — it’s the story of a body under chronic inflammatory pressure. The pancreas, as the metabolic sentinel, falters early but also holds potential for early recovery. And when it recovers, it initiates a cascade of healing that can transform maternal health, hormonal resilience, and lactation outcomes.

This is the deeper story behind the lactogenic diet — not just a list of good foods, but a coordinated strategy to reduce inflammation, restore metabolic function, and support the body where it needs it most.

References:

Beta-Cell Recovery and Function:

Taylor, R., & Al-Mrabeh, A. (2022). Remission of type 2 diabetes and long-term sustainability. Nature Reviews Endocrinology, 18(5), 273–285. 

Taylor, R., Al-Mrabeh, A., Zhyzhneuskaya, S., Peters, C., Barnes, A. C., Aribisala, B. S., … & Holman, R. R. (2018). Remission of human type 2 diabetes requires decrease in liver and pancreas fat content but is dependent upon capacity for β cell recovery. Cell Metabolism, 28(4), 547–556.e3.

Impact of Diet on Inflammation and Beta-Cells:

Basu, S., Yoffe, P., Hills, N., & Lustig, R. H. (2013). The relationship of sugar to population-level diabetes prevalence: An econometric analysis of repeated cross-sectional data. PLOS ONE, 8(2), e57873. 

Hernández-Saavedra, D., & Stanford, K. I. (2019). The regulation of lipokines by environmental factors. Nutrients, 11(10), 2422.

Schwingshackl, L., Missbach, B., König, J., & Hoffmann, G. (2015). Adherence to a Mediterranean diet and risk of diabetes: a systematic review and meta-analysis. Public health nutrition, 18(7), 1292-1299.

Barbaresko, J., Koch, M., Schulze, M. B., & Nöthlings, U. (2013). Dietary pattern analysis and biomarkers of low-grade inflammation: a systematic literature review. Nutrition reviews, 71(8), 511-527.

Li, D., Zhong, J., Zhang, Q., & Zhang, J. (2023). Effects of anti-inflammatory therapies on glycemic control in type 2 diabetes mellitus. Frontiers in Immunology, 14, 1125116.

Ribeiro, C. B., Ramos, F. M., Manthey, J. A., & Cesar, T. B. (2019). Effectiveness of Eriomin® in managing hyperglycemia and reversal of prediabetes condition: A double‐blind, randomized, controlled study. Phytotherapy Research, 33(7), 1921-1933.

Insulin Sensitivity and Lactation:

Nommsen-Rivers, L. A., & Dewey, K. G. (2009). Lactational insulin secretion: Implications for postpartum glucose regulation and breast milk composition. Current Opinion in Clinical Nutrition & Metabolic Care, 12(3), 303–308.

Stuebe, A. M., Rich-Edwards, J. W., Willett, W. C., Manson, J. E., & Michels, K. B. (2005). Duration of lactation and incidence of type 2 diabetes. JAMA, 294(20), 2601–2610. 

Gunderson, E. P., Hurston, S. R., Ning, X., Lo, J. C., Crites, Y., Walton, D., … & Ferrara, A. (2015). Lactation and progression to type 2 diabetes mellitus after gestational diabetes mellitus: A prospective cohort study. Annals of Internal Medicine, 163(12), 889–898.